TELCON RF PHARMACEUTICAL. Inc. (KOSDAQ:200230)

TELCON RF PHARMACEUTICAL. Revenue

In the year 2025, TELCON RF PHARMACEUTICAL. had annual revenue of 43.16B KRW with 13.99% growth. TELCON RF PHARMACEUTICAL. had revenue of 13.32B in the quarter ending December 31, 2025, a decrease of -3.73%.

• Revenue: 43.16B
• Revenue Growth: +13.99%
• P/S Ratio: 0.71
• Revenue / Employee: 342.55M
• Employees: 126
• Market Cap: 30.50B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	43.16B	5.30B	13.99%
Dec 31, 2024	37.87B	1.56B	4.29%
Dec 31, 2023	36.31B	8.48B	30.46%
Dec 31, 2022	27.83B	-10.01B	-26.46%
Dec 31, 2021	37.84B	4.70B	14.18%